Dry Macular Degeneration Treatment is in the works.

At present, dry macular degeneration is not pharmaceutically treatable.  However, things are hopeful for the future. There are 15 major companies with at least 40 drugs in the FDA pipeline. The researchers and the number of treatments for each include:

Acucela Inc. 22
Alimera Sciences, Inc. 23
Bioheart, Inc. 24
Catalyst Biosciences, Inc. 25
Cell Cure Neurosciences, Ltd. 26
Eleven Biotherapeutics Inc. 27
EyeCyte, Inc. 28
Foamix Pharmaceuticals Ltd. 29
Genentech, Inc. 30
GlaxoSmithKline plc 31
Icon Bioscience, Inc. 32
Inotek Pharmaceuticals Corporation 33
MacuCLEAR, Inc. 34
Neurotech Pharmaceuticals, Inc. 35
Ocata Therapeutics, Inc. 36
Ophthotech Corp. 37
pSivida Corp. 38
Tacere Therapeutics, Inc. 39

In the meantime, there are innumerable assistive devices available to help you cope with the problem.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: